INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 216 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $70,820 | -27.0% | 86,366 | +38.8% | 0.00% | -60.0% |
| Q4 2022 | $97,034 | -23.6% | 62,201 | -15.5% | 0.01% | +25.0% |
| Q3 2022 | $127,000 | -2.3% | 73,597 | +1.7% | 0.00% | 0.0% |
| Q2 2022 | $130,000 | -44.2% | 72,362 | +13.4% | 0.00% | -20.0% |
| Q1 2022 | $233,000 | -29.4% | 63,817 | +0.4% | 0.01% | -28.6% |
| Q4 2021 | $330,000 | -40.9% | 63,584 | -17.2% | 0.01% | -30.0% |
| Q3 2021 | $558,000 | -4.5% | 76,809 | +24.4% | 0.01% | 0.0% |
| Q2 2021 | $584,000 | +4.1% | 61,764 | -3.0% | 0.01% | 0.0% |
| Q1 2021 | $561,000 | -24.4% | 63,673 | -22.7% | 0.01% | -37.5% |
| Q4 2020 | $742,000 | -38.7% | 82,399 | -23.0% | 0.02% | -57.9% |
| Q3 2020 | $1,211,000 | -38.4% | 107,051 | +72.6% | 0.04% | -45.7% |
| Q2 2020 | $1,965,000 | – | 62,020 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |